Cargando…

Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study

INTRODUCTION: The adequate protection provided by the del Nido cardioplegia has already been proven in trials comparing the solution with blood cardioplegia. However, evidence regarding comparison to the Bretschneider HTK solution is limited. AIM: To determine the efficacy of the del Nido cardiopleg...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanetra, Krzysztof, Domaradzki, Wojciech, Białek, Krzysztof, Shrestha, Rajesh, Bochenek, Andrzej, Jankowska-Sanetra, Justyna, Buszman, Piotr P., Gerber, Witold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290408/
https://www.ncbi.nlm.nih.gov/pubmed/35891993
http://dx.doi.org/10.5114/kitp.2022.117496
_version_ 1784748892916547584
author Sanetra, Krzysztof
Domaradzki, Wojciech
Białek, Krzysztof
Shrestha, Rajesh
Bochenek, Andrzej
Jankowska-Sanetra, Justyna
Buszman, Piotr P.
Gerber, Witold
author_facet Sanetra, Krzysztof
Domaradzki, Wojciech
Białek, Krzysztof
Shrestha, Rajesh
Bochenek, Andrzej
Jankowska-Sanetra, Justyna
Buszman, Piotr P.
Gerber, Witold
author_sort Sanetra, Krzysztof
collection PubMed
description INTRODUCTION: The adequate protection provided by the del Nido cardioplegia has already been proven in trials comparing the solution with blood cardioplegia. However, evidence regarding comparison to the Bretschneider HTK solution is limited. AIM: To determine the efficacy of the del Nido cardioplegia when compared to Bretschneider HTK solution in patients undergoing aortic valve replacement for severe aortic stenosis. MATERIAL AND METHODS: Ten patients undergoing isolated aortic valve replacement for severe aortic stenosis using the del Nido solution (group 1) were case-control matched to patients undergoing aortic valve replacement (AVR) using the Bretschneider solution (group 2). The observation included: cardioplegia dosage, time to cardiac arrest, cross-clamp and extracorporeal circulation time, ventricular fibrillation (VF) after removing the cross-clamp, gasometry parameters, creatinine kinase (MB isoenzyme – CK-MB) at 24 and 48 h following the surgery and troponin (highsensitivity troponin T – hsTnT) at 24 and 48 h. RESULTS: Patients were no different in terms of comorbidities. Higher incidence of VF occurred in group 2 (3 vs. 9, 30% vs. 90%; p = 0.02). Blood sodium measurements after removing the cross-clamp were significantly higher in group 1 (median 137.0 vs. 130.0; p = 0.0004). Biomarker release trended toward lower values in group 1, but not significantly (median troponin at 24 h: 223.1 pg/ml vs. 294.8 pg/ml; p = 0.4 and 48 h: 208.0 pg/ml vs. 242.5 pg/ml; p = 0.7, median CK-MB at 24 h: 16.6 ng/ml vs. 17.3 ng/ml; p = 0.6, and 48 h: 6.7 ng/ml vs. 5.08 ng/ml; p = 0.3). Peak creatinine trended towards lower values in group 2, but not significantly (1.35 mg/dl vs. 1.05 mg/dl; p = 0.09). CONCLUSIONS: Both del Nido and Bretschneider cardioplegia provide satisfactory myocardial protection. However, del Nido cardioplegia reduces the incidence of VF after declamping the aorta. Further studies are required.
format Online
Article
Text
id pubmed-9290408
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-92904082022-07-25 Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study Sanetra, Krzysztof Domaradzki, Wojciech Białek, Krzysztof Shrestha, Rajesh Bochenek, Andrzej Jankowska-Sanetra, Justyna Buszman, Piotr P. Gerber, Witold Kardiochir Torakochirurgia Pol Original Paper INTRODUCTION: The adequate protection provided by the del Nido cardioplegia has already been proven in trials comparing the solution with blood cardioplegia. However, evidence regarding comparison to the Bretschneider HTK solution is limited. AIM: To determine the efficacy of the del Nido cardioplegia when compared to Bretschneider HTK solution in patients undergoing aortic valve replacement for severe aortic stenosis. MATERIAL AND METHODS: Ten patients undergoing isolated aortic valve replacement for severe aortic stenosis using the del Nido solution (group 1) were case-control matched to patients undergoing aortic valve replacement (AVR) using the Bretschneider solution (group 2). The observation included: cardioplegia dosage, time to cardiac arrest, cross-clamp and extracorporeal circulation time, ventricular fibrillation (VF) after removing the cross-clamp, gasometry parameters, creatinine kinase (MB isoenzyme – CK-MB) at 24 and 48 h following the surgery and troponin (highsensitivity troponin T – hsTnT) at 24 and 48 h. RESULTS: Patients were no different in terms of comorbidities. Higher incidence of VF occurred in group 2 (3 vs. 9, 30% vs. 90%; p = 0.02). Blood sodium measurements after removing the cross-clamp were significantly higher in group 1 (median 137.0 vs. 130.0; p = 0.0004). Biomarker release trended toward lower values in group 1, but not significantly (median troponin at 24 h: 223.1 pg/ml vs. 294.8 pg/ml; p = 0.4 and 48 h: 208.0 pg/ml vs. 242.5 pg/ml; p = 0.7, median CK-MB at 24 h: 16.6 ng/ml vs. 17.3 ng/ml; p = 0.6, and 48 h: 6.7 ng/ml vs. 5.08 ng/ml; p = 0.3). Peak creatinine trended towards lower values in group 2, but not significantly (1.35 mg/dl vs. 1.05 mg/dl; p = 0.09). CONCLUSIONS: Both del Nido and Bretschneider cardioplegia provide satisfactory myocardial protection. However, del Nido cardioplegia reduces the incidence of VF after declamping the aorta. Further studies are required. Termedia Publishing House 2022-06-29 2022-06 /pmc/articles/PMC9290408/ /pubmed/35891993 http://dx.doi.org/10.5114/kitp.2022.117496 Text en Copyright: © 2022 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Sanetra, Krzysztof
Domaradzki, Wojciech
Białek, Krzysztof
Shrestha, Rajesh
Bochenek, Andrzej
Jankowska-Sanetra, Justyna
Buszman, Piotr P.
Gerber, Witold
Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
title Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
title_full Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
title_fullStr Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
title_full_unstemmed Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
title_short Del Nido versus Bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
title_sort del nido versus bretschneider cardioplegic solution in valve replacement for severe aortic stenosis – a case-control pilot study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290408/
https://www.ncbi.nlm.nih.gov/pubmed/35891993
http://dx.doi.org/10.5114/kitp.2022.117496
work_keys_str_mv AT sanetrakrzysztof delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT domaradzkiwojciech delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT białekkrzysztof delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT shrestharajesh delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT bochenekandrzej delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT jankowskasanetrajustyna delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT buszmanpiotrp delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy
AT gerberwitold delnidoversusbretschneidercardioplegicsolutioninvalvereplacementforsevereaorticstenosisacasecontrolpilotstudy